Xu L - Search Results

1

Can Immediately Treating Subcentimeter Hepatocellular Carcinoma Improve the Survival of Patients?

Sun X, Hu D, Zhang Y, Lyu N, Xu L, Chen Q, Lai J, Chen M, Zhao M. Sun X, et al. Among authors: xu l. J Hepatocell Carcinoma. 2020 Dec 16;7:377-384. doi: 10.2147/JHC.S287641. eCollection 2020. J Hepatocell Carcinoma. 2020. PMID: 33365285 Free PMC article.

2

[Clinicopathologic features and treatment outcomes of primary hepatic lymphoma: a report of four cases].

Zhang YJ, Chen MS, Liang HH, Xu L, Zhang YQ. Zhang YJ, et al. Among authors: xu l. Ai Zheng. 2005 Mar;24(3):365-7. Ai Zheng. 2005. PMID: 15757544 Chinese.

3

[Prophylaxis and clinical treatment for surgical margin recurrence of small primary hepatocellular carcinoma].

Fang WQ, Li SP, Zhang CQ, Xu L, Shi M, Chen MS, Li JQ. Fang WQ, et al. Among authors: xu l. Ai Zheng. 2005 Jul;24(7):834-6. Ai Zheng. 2005. PMID: 16004810 Chinese.

4

[Inhibitory effects of iressa on hepatocellular carcinoma Hep-3B and HepG2 cell xenografts in nude mice].

Xu L, Zhang YJ, Lin XJ, Li JQ. Xu L, et al. Ai Zheng. 2006 Apr;25(4):447-50. Ai Zheng. 2006. PMID: 16613678 Chinese.

5

[Experience of radiofrequency ablation on liver malignancies: a report of 803 cases].

Chen MS, Zhang YJ, Li JQ, Liang HH, Zhang YQ, Lin XJ, Zheng Y, Xu L, Wan YL. Chen MS, et al. Among authors: xu l. Zhonghua Wai Ke Za Zhi. 2007 Nov 1;45(21):1469-71. Zhonghua Wai Ke Za Zhi. 2007. PMID: 18275711 Chinese.

6

[Percutaneous radiofrequency ablation combined with other minimally invasive treatments for recurrent hepatocellular carcinoma after hepatectomy].

Xu L, Li P, Chen MS, Pang XH, Gao HJ, Peng ZW, Liang HH, Zhang YJ, Li JQ. Xu L, et al. Zhonghua Wai Ke Za Zhi. 2008 Nov 1;46(21):1617-20. Zhonghua Wai Ke Za Zhi. 2008. PMID: 19094753 Chinese.

7

[Clinical observation of sorafenib monotherapy in Chinese patients with advanced hepatocellular carcinoma].

Xu L, Li P, Lin XJ, Yuan YF, Zhang YQ, Chen MS. Xu L, et al. Zhonghua Zhong Liu Za Zhi. 2009 Jan;31(1):58-61. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19538872 Clinical Trial. Chinese.

8

Role of radiofrequency ablation in the treatment of hepatocellular carcinoma: experience of a cancer center in China.

Chen MS, Peng ZW, Xu L, Zhang YJ, Liang HH, Li JQ. Chen MS, et al. Among authors: xu l. Oncology. 2011;81 Suppl 1:100-4. doi: 10.1159/000333268. Epub 2011 Dec 22. Oncology. 2011. PMID: 22212942

9

Elevated neutrophil to lymphocyte ratio might predict poor prognosis for colorectal liver metastasis after percutaneous radiofrequency ablation.

Zhang Y, Peng Z, Chen M, Liu F, Huang J, Xu L, Zhang Y, Chen M. Zhang Y, et al. Among authors: xu l. Int J Hyperthermia. 2012;28(2):132-40. doi: 10.3109/02656736.2011.654374. Int J Hyperthermia. 2012. PMID: 22335227 Free article.

10

High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy.

Liu F, Zhang Y, Peng Z, Gao H, Xu L, Chen M. Liu F, et al. Among authors: xu l. J Transl Med. 2012 Jul 2;10:135. doi: 10.1186/1479-5876-10-135. J Transl Med. 2012. PMID: 22747650 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42,091 results

Search Page

Filters